Noradrenaline and 5-hydroxytryptamine modulation of brain dopamine function: implications for the treatment of Parkinson's disease (Q40144741)
scientific article published on January 1, 1983
Language:
(P31) (Q13442814)
(P50) (Q18546138)
(P304) 277S-289S
(P407) (Q1860)
(P433) S2
(P478) 15 Suppl 2
(P577) Saturday, January 1, 1983
(P921) (Q186242)
(Q128406)
(P953) https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1365-2125.1983.tb05876.x
https://europepmc.org/articles/PMC1427871
https://europepmc.org/articles/PMC1427871?pdf=render
https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1365-2125.1983.tb05876.x
http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2125.1983.tb05876.x/fullpdf
(P1433) (Q176044)
(P1476) "Noradrenaline and 5-hydroxytryptamine modulation of brain dopamine function: implications for the treatment of Parkinson's disease" (language: en)
(P2093) P. Jenner
M. Sheehy
(P2860) (Q37272987)
(Q34716716)
(Q40099110)
(Q39888880)
(Q28333787)
(Q28330228)
(Q40019836)
(Q39761971)
(Q39735793)
(Q39490606)
(Q39212856)
(Q39104134)
(Q39099103)
(Q51116310)
(Q43647905)
(Q43976575)
(Q43748604)
(Q48499340)
(Q48770465)
(Q48595124)
(Q48506055)
(Q42439023)
(Q48497944)
(Q48610961)
(Q48679287)
(Q48725530)
(Q48875313)
(Q43731009)
(Q48434532)
(Q48434958)
(Q45025589)
(Q48487176)
(Q48477580)
(Q46265530)
(Q44621014)
(Q44836355)
(Q48291791)
(Q48364298)
(Q41883255)
(Q48168348)
(Q48243819)
(Q48160624)
(Q45077223)
(Q44928115)
(Q48360224)
(Q64916150)
(Q68500863)
(Q70666531)
(Q64800660)
(Q67224420)
(Q67222511)
(Q64865730)
(Q72424821)
(Q67019453)
(Q64998246)
(Q64860693)
(P13046) (Q7318358)
other details
description scientific article published on January 1, 1983

External Links